#Singapore #Las Vegas #glucose monitoring #CES 2026 #Sensura

Sensura to Present Innovations at CES 2026

During the CES 2026 event held from January 6 to 9 in Las Vegas, Sensura, a pioneering deep-tech company from Singapore, is set to unveil its latest innovations in health monitoring. With a strong focus on enhancing health and wellness, Sensura is introducing a groundbreaking non-invasive health monitoring platform that marks a significant leap in diabetes management.

A Closer Look at Sensura's Technology

The centerpiece of Sensura's presentation at CES 2026 will be their prototype for glucose monitoring that operates without the need for invasive procedures like finger pricks. This innovative platform comprises two device forms: a handheld unit designed for quick spot checks and a wearable device that allows for continuous glucose monitoring throughout the day. Designed for both medical professionals and everyday users, these devices aim to change the way people manage their metabolic health.

Handheld and Wearable Devices

The handheld device is user-friendly, making it suitable for both clinical settings and everyday home use. It enables users to perform rapid and painless checks of their glucose levels. This tool is crucial for individuals who might struggle with pain or discomfort from conventional glucose monitoring methods.

On the other hand, the wearable device provides real-time insights into glucose trends, offering users a comprehensive understanding of how their dietary choices, physical activities, and lifestyle decisions affect their overall health. This continuous monitoring feature can significantly improve the way individuals manage their lives around diabetes.

Addressing Challenges in Diabetes Management

As Hongzhi Zheng, the Founder and CEO of Sensura, points out, long-term adherence to glucose monitoring is challenging when the methods are uncomfortable or cumbersome. The popular reliance on invasive techniques often discourages individuals from maintaining consistent health checks. Sensura's goal is to eliminate these barriers, making health monitoring easy and accessible through everyday technology.

By employing proprietary optical sensing technology, a specialized chip architecture, and advanced AI analytics, Sensura’s devices promise effective continuous data capture without the user burden often associated with standard glucose monitoring practices. This approach not only relieves the discomfort tied to traditional methods but also promotes sustained engagement in health monitoring.

CES 2026: A Stepping Stone to Greater Impact

At their booth, number 35301 in Hall 2, Sensura will display live demonstrations of its prototypes, explaining the technological framework and future product strategies. The company plans to showcase how they aim to expand beyond glucose tracking to embrace a wider range of health and wellness applications over time.

Zheng emphasizes the importance of CES 2026 in their journey, stating, “This event serves as a crucial juncture as we shift from just a prototype stage to a more interactive validation process. Engaging with global healthcare pioneers and tech partners at CES is vital as we aim to build strong relationships in our innovation ecosystem.”

Following CES, the Sensura team will further its discussions with industry stakeholders at the J.P. Morgan Healthcare Conference in San Francisco, seeking collaborative opportunities to realize their vision of accessible health monitoring.

About Sensura

Headquartered at the Temasek Life Sciences Laboratory within the National University of Singapore, Sensura is at the forefront of developing next-generation health and wellness monitoring solutions. With their unique focus on non-invasive technologies, Sensura aims to facilitate earlier detection of health issues, enhance preventive care practices, and improve long-term health outcomes, especially for those managing diabetes. Their innovative approach promises a future where health management is a seamless part of everyday life, paving the way for better health for individuals everywhere.